Angela M. Starks

Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis

Patricia Campbell, Glenn P. Morlock, R. David Sikes et al. · Antimicrobial Agents and Chemotherapy · 2011 · 378 citations

Life Sciences, Pharmacology, Antimicrobial Pharmacology +16

A standardised method for interpreting the association between mutations and phenotypic drug resistance in<i>Mycobacterium tuberculosis</i>

Paolo Miotto, Belay Tessema, Elisa Tagliani et al. · European Respiratory Journal · 2017 · 333 citations · Full text

Life Sciences, Genetics, Microbiology +17

Molecular Pathogenesis of Vibrio vulnificus.

Paul A. Gulig, Keri L. Bourdage, Angela M. Starks · PubMed · 2005 · 247 citations

Life Sciences, Infectious Diseases, Microbiology +14

Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

Jussi Saukkonen, Raquel Duarte, Sonal S. Munsiff et al. · American Journal of Respiratory and Critical Care Medicine · 2024 · 124 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17

Pathogenesis of Infection by Clinical and Environmental Strains of <i>Vibrio vulnificus</i> in Iron-Dextran-Treated Mice

Angela M. Starks, Trenton R. Schoeb, Mark L. Tamplin et al. · Infection and Immunity · 2000 · 101 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17